US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...
from NDTV News - World-news https://ift.tt/36lyTbO
Subscribe to:
Post Comments (Atom)
In Siding With Russia Over Ukraine, What Is Trump's Strategy?
Has any nation squandered its diplomatic capital, plundered its own political system, attacked its partners and supplicated itself before it...
No comments:
Post a Comment